Objective-Phosphatidylserine exposure mediates platelet procoagulant function and regulates platelet life span.
P hosphatidylserine externalization facilitates coagulation and acts as a signal for cell clearance. 1, 2 Increased phosphatidylserine externalization on the platelet surface allows assembly of coagulation factor complexes, 3 increased thrombin generation, 4 and fibrin formation. 5 In platelets, distinct apoptotic and agonist-initiated mechanisms have been implicated in the regulation of phosphatidylserine externalization. 6 Common to both of these mechanisms is the central role of the mitochondrion and mitochondrially mediated events.
When platelets are strongly stimulated, a subpopulation of activated platelets exposes high levels of phosphatidylserine on their surface. 7, 8 In these agonist-initiated procoagulant platelets, sustained calcium elevation 9 and cyclophilin D-mediated mitochondrial permeability transition pore (mPTP) formation 10, 11 play key roles in the regulation of phosphatidylserine externalization. The mPTP is an inducible, large, and nonselective pore that is formed within the inner mitochondrial membrane (IMM). 12 Sustained mPTP formation results in IMM disruption, loss of mitochondrial transmembrane potential (ΔΨ m ), and mitochondrial swelling. Because this process is morphologically analogous to that observed in cells undergoing necrosis, these agonist-initiated procoagulant platelets have also been referred to as necrotic platelets. 6 Treatment of platelets with a BcL-xL inhibitor, such as ABT-737, also results in phosphatidylserine externalization. 2, 13 Inhibition of BcL-xL results in Bax/Bak-mediated caspase activation, phosphatidylserine externalization, and in vivo platelet clearance. 2, 14 Apoptosome formation in Bax/ Bak-mediated apoptosis is dependent on disruption of the outer mitochondrial membrane and cytochrome c release from the intermembrane space to the cytoplasm. In contrast to agonist-initiated phosphatidylserine externalization, the relationship of ΔΨ m with apoptotic phosphatidylserine externalization is less well characterized with varying reports regarding whether ΔΨ m is lost or maintained in the apoptotic platelet. 6, 15 An integrin-mediated pathway of platelet phosphatidylserine externalization has been characterized in platelets stimulated with a high concentration of thrombin. 16 Unlike apoptotic platelets or platelets stimulated with agonists, phosphatidylserine externalization in these integrin-dependent procoagulant platelets was associated neither with increased concentrations of cytoplasmic calcium nor with mitochondrial membrane depolarization. Thus, this pathway would represent a novel mechanism of agonist-initiated phosphatidylserine externalization not associated with a necrotic mechanism of cell death.
Here, we dissect the mitochondrial events occurring in platelets with regulated externalization of phosphatidylserine. Novel platelet flow cytometric assays were developed to allow a detailed kinetic and mechanistic examination of how and when mitochondrial events participate in platelet phosphatidylserine externalization. Using these novel assays and through the kinetic examination of mitochondrial events in platelets, IMM disruption is shown to be closely and temporally associated with phosphatidylserine externalization in each of these disparate pathways. Delineation of integrinmediated phosphatidylserine externalization revealed a close interaction of procoagulant platelets with activated and nonphosphatidylserine-externalized platelets providing insights into a potential cellular mechanism of procoagulant platelet retention within a hemostatic thrombus.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results

Inner and Outer Mitochondrial Membrane Disruption and Phosphatidylserine Externalization in Platelets
A key event in apoptotic cell death is the release of cytochrome c from the mitochondrial intermembrane space to the cytosol. 17 Controlled digitonin permeabilization of the plasma membrane can be used to examine retention of cytochrome c within the mitochondrial intermembrane space. 18 Cytochrome c release was examined in platelets after treatment with ABT-737 for 30 and 90 minutes. In untreated platelets, cytochrome c is retained as measured by staining with a labeled anti-cytochrome c antibody. In contrast, cytochrome c in ABT-737-treated platelets is not retained after digitonin permeabilization ( Figure 1A ). This can be attributed to mitochondrial outer membrane permeabilization (MOMP) and cytochrome c release to the cytosol. To directly examine IMM disruption, a calcein-cobalt assay was used. 19 Cobalt is normally excluded from the mitochondrial matrix. IMM disruption in calcein-and cobalt-loaded platelets results in cobalt entry into the mitochondrial matrix and a quenching of the remaining calcein fluorescence. Increased IMM disruption, as assessed by quenching of the calcein fluorescence, was observed in ABT-737-treated platelets ( Figure 1B ).
Using these cytometric assays, a detailed kinetic analysis of mitochondrial events and phosphatidylserine externalization was performed in platelets after exposure to ABT-737 ( Figure 1C ) and to the agonists thrombin and convulxin ( Figure 1D ). Treatment of platelets with ABT-737 resulted in rapid loss of cytochrome c consistent with Bcl-2 proteinmediated MOMP. Cytochrome c release occurred much more rapidly than phosphatidylserine externalization in ABT-737-treated platelets. Whereas MOMP (as assessed by cytochrome c loss) was at a maximum within 10 minutes, maximal phosphatidylserine externalization was not observed until 60 minutes after treatment. Investigation of IMM disruption demonstrated that, unlike MOMP, IMM disruption temporally coincided with phosphatidylserine externalization. Dual agonist stimulation resulted in rapid IMM disruption ( Figure 1D ) consistent with the established importance of mPTP formation in the regulation of agonist-initiated phosphatidylserine externalization. Notably, similar to ABT-737-treated platelets, IMM disruption and phosphatidylserine externalization were temporally correlated. Interestingly, loss of cytochrome c was not observed in agonist-stimulated platelets over the examined time frame. This is consistent with the known minimal role of Bcl-2 proteins in agonist-mediated phosphatidylserine externalization. 6 
Mitochondrial Mechanisms Regulating Phosphatidylserine Externalization in Apoptotic Platelets
Mitochondrial events were examined in Bax/Bak doubleknockout (apoptosis-resistant) platelets and caspase inhibitor (10 μmol/L Q-VD-Oph) pretreated platelets after ABT-737 treatment. Phosphatidylserine externalization, IMM disruption, and cytochrome c release were all completely inhibited in Bax/Bak double-knockout platelets consistent with ABT-737's mechanism of action and dependence on Bax/ Bak-mediated MOMP (Figure 2A and 2C) . Caspase activity mediates events downstream of cytochrome c-initiated apoptosome formation. Accordingly, MOMP formation was unperturbed by caspase inhibition ( Figure 2B and 2C). As has been previously shown, caspase inhibition markedly abrogated ABT-737-initiated phosphatidylserine externalization in platelets.
14 IMM disruption was similarly blunted in 
Visualization of Mitochondrial Disruption in Phosphatidylserine-Externalizing Platelets
IMM disruption results in mitochondrial swelling because of influx of water into the mitochondrial matrix through the formerly impermeable IMM. 20 In contrast, the presence of an intact IMM limits swelling in mitochondria that have recently undergone MOMP. MitoTracker-stained mitochondria were visualized in platelets. Unlike tetramethyl rhodamine methylester (TMRM), MitoTracker undergoes covalent binding to the thiol groups of mitochondrial proteins and is retained after fixation or within depolarized mitochondria. When stimulated by agonists that cause minimal phosphatidylserine externalization, no change in mitochondrial area per platelet was noted by confocal microscopy. Small punctate organelles were stained in unstimulated and thrombin-stimulated platelets ( Figure 3A , 3B, and 3F). Similarly, the mitochondrial depolarizing agent CCCP (carbonyl cyanide m-chlorophenyl hydrazone; 10 μmol/L) had no effect on mitochondrial area consistent with the presence of structurally intact mitochondria ( Figure 3D and 3F). To allow simultaneous examination of annexin V-negative and annexin V-positive populations, threshold conditions were used to stimulate high-level phosphatidylserine externalization using the agonists thrombin and convulxin and the apoptotic stimulus ABT-737. Significant mitochondrial swelling was seen in platelets with high levels of phosphatidylserine externalization as measured by annexin V binding ( Figure 3C , 3E, and 3F). In annexin V-negative platelets, no increase in mitochondrial area was noted. Together, these results are consistent with those obtained using A-E, Anti-CD41 (blue), MitoTracker (purple), and annexin V (ann V; green) were used to stain human platelets treated/stimulated as indicated, which were visualized using confocal microscopy. Bar=2 µm. F, Relative mitochondrial area/platelet was assessed in ann V + and ann V − platelets (n≥3). *P<0.05 vs unstimulated platelets.
calcein-cobalt assay, demonstrating the close correlation of IMM disruption, as assessed here by mitochondrial swelling, with high-level phosphatidylserine externalization in both agonist-stimulated and apoptotic platelets.
Mechanisms Regulating Integrin-Dependent Phosphatidylserine Externalization
Although loss of mitochondrial integrity, as demonstrated here ( Figure 1 ) and previously, 10 is strongly correlated with phosphatidylserine externalization in both apoptotic and agonist-stimulated (necrotic) platelets, integrin-dependent phosphatidylserine externalization has not been correlated with changes in mitochondrial integrity. 16 First, we validated integrin-dependent phosphatidylserine exposure in murine platelets using similar platelet concentrations and similarly high levels of stimulation with thrombin. As has been demonstrated, 2 distinct phosphatidylserine-externalizing subpopulations could be distinguished by flow cytometry: (1) phosphatidylserine-externalizing platelets with high intracellular calcium (loss of FuraRed staining ( Figure 4A , i) or low intracellular calcium (maintenance of FuraRed staining; Figure 4A , ii); (2) phosphatidylserine-externalizing platelets with loss of mitochondrial transmembrane potential (ΔΨ m ; low TMRM staining [ Figure 4B , i]) or maintenance of Figure 4B , ii]); and (3) phosphatidylserine-externalizing platelets with low (i) or high (ii) JON/A staining, consistent with the absence or presence of activated integrin α IIb β 3 , as recognized by the activation-specific antibody JON/A, respectively ( Figure 4C ). Of note, the characteristics of platelet subpopulation i, such as high cytosolic calcium level and loss of mitochondrial integrity, correspond closely with the classically described agonist-initiated phosphatidylserine-externalizing subpopulation. 21 Population ii corresponds with the integrin-dependent phosphatidylserine-externalizing platelet subpopulation, of which the described characteristics include a normal cytosolic calcium level and intact mitochondria. 16 To investigate the role of mitochondrially regulated cell death mechanisms in regulating phosphatidylserine externalization in these 2 distinct subpopulations, platelets were obtained from Bax/Bak double-knockout mice (apoptosisresistant mice because of impaired MOMP formation) 2 and cyclophilin D knockout mice, which have markedly abrogated mPTP formation and phosphatidylserine externalization. 10 As apoptosis in platelets occurs independent of large changes in calcium flux, 22, 23 it was initially hypothesized that formation of the novel cytometric subpopulation (population ii) would be driven by Bax/Bak and that formation of the high calcium platelets with loss of ΔΨ m (population i) would be driven by cyclophilin D. However, deletion of Bax/Bak had no effect on the formation of the integrin-mediated phosphatidylserineexternalizing cytometric subpopulation ( Figure 4D through 4F, population ii, gray bar). Rather, cyclophilin D deletion prevented formation of population ii ( Figure 4D through 4F, population ii, black bar), even though loss of TMRM staining, a well-established marker of mPTP formation, was not observed in population ii of wild-type mice ( Figure 4B , ii). This surprising finding initially suggested a potentially novel role for cyclophilin D distinct from its well-characterized role in regulating mPTP formation. As expected, the formation of platelets with the characteristics of population i, the classic phosphatidylserine-externalizing platelet, was dependent on cyclophilin D (Figure 4D through 4F, population i, black bar).
Classical phosphatidylserine-externalizing platelets have distinct forward scatter characteristics and side scatter characteristics. Examination of the integrin-dependent cytometric subpopulation demonstrated that they had forward scatter characteristics and side scatter characteristics ( Figure 5A , population ii, black) distinct from classical phosphatidylserine-externalizing platelets ( Figure 5A , population i, gray) and also had slightly larger forward scatter characteristics and side scatter characteristics than the subpopulation of annexin V-negative activated platelets ( Figure 5A, red) . This pattern, together with the previously demonstrated integrin dependence of the novel cytometric subpopulation and its dependence on cyclophilin D, suggested an alternative explanation for the formation of population ii. To investigate the possibility that the novel subpopulation might be a consequence of small aggregates (>1 platelet) consisting of platelets with different characteristics, Cell Tracker Violet (CTV)-or Cell Tracker Green (CTG)-labeled platelets were mixed and stimulated with 100 nmol/L thrombin ( Figure 5B) . A substantial fraction of the platelet events at higher platelet concentrations were positive for both stains consistent with the formation of small platelet aggregates as the platelet concentration increased. Also, consistent with this hypothesis, abrogation of aggregation using an integrin α IIb β 3 antagonist (eptifibatide, 2 μg/mL) approximately halved the formation of population ii as had been previously demonstrated by Topalov et al 16 ( Figure  I in the online-only Data Supplement).
Image Cytometry of Activated Platelets in Suspension
Image cytometry was used to visualize the integrin-dependent phosphatidylserine-externalizing platelet subpopulations. Platelets separately labeled with CTV and CTG were mixed, stimulated with 100 nmol/L thrombin, and assessed with the platelet activation markers JON/A and annexin V. Figure 5C Figure 5D and 5E). Nearly all events consistent with the characteristics of the novel integrin-dependent subpopulation consisted of small platelet aggregates with 1 phosphatidylserine-positive platelet and ≥1 phosphatidylserine-negative platelet(s). More than 95% of JON/A high and annexin V + events could be clearly distinguished as a small platelet aggregate (>1 platelet). In contrast, in <5% of JON/A low and annexin V + events could an aggregate be distinguished. A similar pattern of aggregate formation was observed when TMRM and annexin V were used ( Figure 5E , bottom). This same analysis using image cytometry of human platelets using PAC-1 (antihuman glycoprotein IIb/IIIa complex antibody) and annexin V revealed almost identical results ( Figure II in the online-only Data Supplement).
Procoagulant Platelets Participate in Aggregates In Vitro and In Vivo
Transmission electron microscopy studies were used to investigate whether similar interactions between activated and procoagulant platelets as observed in population ii might occur in vivo. Thrombin-and convulxin-stimulated platelets in suspension were examined by transmission electron microscopy 1 minute and 7 minutes after stimulation ( Figure 6A ). One minute after stimulation, a distinct procoagulant platelet subpopulation could not be identified, a result that is consistent with delayed formation of the procoagulant platelet subpopulation relative to other earlier platelet activation events, such as granule release or integrin activation. 8, 27 Seven minutes after initial stimulation, 2 subpopulations of platelets could be clearly identified based on their distinct appearances and electron density characteristics. These consisted of a population of platelets with similar characteristics to that observed 1 minute after stimulation and an electron-lucent balloonlike population. The electron-lucent balloon-like platelets could be identified as the procoagulant platelet subpopulation based on their greatly decreased formation in platelets obtained from cyclophilin D knockout mice ( Figure 6A , bottom) and their limited formation among platelets stimulated with thrombin alone (data not shown). Here, among wild-type platelets, interaction of procoagulant and activated platelets was occasionally seen consistent with the results obtained using image cytometry ( Figure 6B ). Similarly, examination of the periphery of murine hemostatic plugs obtained 5 minutes after injury of a mesenteric venule demonstrated interaction of interrupted populations of peripheral electron-lucent platelets with a central core of more electron-dense platelets ( Figure 6C ). Together, these results indicate that activated platelets interact with procoagulant platelets and indicate a potential mechanism for the retention of procoagulant platelets within the forming hemostatic plug. 
Discussion
In this study, the roles of specific mitochondrial events in phosphatidylserine exposure were carefully dissected. Intriguingly, high-level phosphatidylserine externalization induced both by platelet agonist(s) and by apoptotic stimuli was mechanistically and kinetically associated with IMM disruption, evidenced by alteration in the permeability of the normally IMM-impermeant ion cobalt and by the presence of mitochondrial swelling, an indicator of free water entry into the highly osmotic mitochondrial matrix. In contrast, MOMP could be dissociated from phosphatidylserine externalization in both apoptotic and agonist-stimulated platelets. No correlation of MOMP with phosphatidylserine externalization was noted in agonist-stimulated platelets, and in apoptotic platelets, MOMP was not temporally correlated with phosphatidylserine exposure but instead preceded phosphatidylserine externalization. Furthermore, caspase inhibition, although markedly abrogating phosphatidylserine externalization, had minimal effect on MOMP.
The studies here point to a link between physical disruption of the IMM and phosphatidylserine exposure. IMM disruption, unless corrected, invariably results in a loss of ΔΨ m because of disruption of the physical barrier to ion movement. That the effect of IMM disruption is not mediated through its effects on ΔΨ m is evidenced by studies here and by others. 15, 28 In the absence of evidence of physical disruption of the IMM, as when induced by using a membrane uncoupler, loss of ΔΨ m has no association with immediate phosphatidylserine externalization. The mechanism by which IMM disruption might cause scramblase activation remains to be identified. Calcium-dependent and caspase-dependent components of scramblase activity have recently been elucidated. TMEM16F is a calcium-dependent membrane protein required for normal phosphatidylserine externalization in response to agonist stimulation. 29 Increased calcium elevation has been suggested as the mechanism regulating scramblase activation and TMEM16F function. 30 Whether cytoplasmic calcium elevation is the sole regulator of agonist-induced phosphatidylserine externalization has been questioned. Detailed studies examining loss of ΔΨ m and calcium transients in agoniststimulated platelets have demonstrated close association of mPTP formation and phosphatidylserine externalization. 21 In marked contrast, the level of cytoplasmic calcium elevation could be readily dissociated from phosphatidylserine externalization. Together, these data point to an essential role for an mPTP-regulated mediator as an upstream signal regulating scramblase activation, most likely in coordination with an essential regulatory function mediated by cytosolic calcium elevation.
In apoptotic cells, Xkr8 has been identified as a novel caspase-dependent component of the scramblase machinery. 31 Caspase-dependent cleavage of Xkr8 potentiates phosphatidylserine externalization in apoptotic cells. The data presented here suggest that coordinated caspase-dependent permeabilization of the IMM, distinct from cyclophilin D-mediated IMM permeabilization, might function to regulate phosphatidylserine exposure in the apoptotic context. Such a potential mediator is suggested by the close link between IMM disruption and phosphatidylserine externalization in both wildtype and caspase-inhibited platelets. Although the nature of such a potential mediator is not identified here, the concept that mitochondrial proteins or factors can be co-opted to act as a signal mediating apoptotic or necrotic events has clear precedent. 17 In addition to its role in the regulation of classic agoniststimulated procoagulant platelet formation, cyclophilin D is demonstrated here to play an important role in mediating integrin-regulated procoagulant platelet formation. 16 Distinct from classical agonist-initiated procoagulant platelet formation, this pathway of phosphatidylserine externalization had been demonstrated using cytometric assays to be associated with neither elevated levels of cytoplasmic calcium nor with loss of ΔΨ m . Other unique characteristics of this phosphatidylserine-externalizing subpopulation included maintenance of integrin α IIb β 3 in an activated state and its dependence on a high-platelet concentration and integrin function. It is demonstrated here that it is highly probable that the flow cytometry event identified by Topalov et al, 16 in fact, consists of an aggregate of an activated, aggregatory platelet, and a classical procoagulant platelet. Consistent with their results, activation of washed platelets resulted in the formation of 2 distinct phosphatidylserine-positive events, 1 of which had the characteristics of agonist-induced procoagulant platelets 32 and a second with the characteristics described by Topalov et al. 16 Mixing studies and image cytometry clearly demonstrate that the unique characteristics of this cytometric subpopulation could be accounted for by the formation of an aggregate consisting of an activated phosphatidylserine-negative platelet and a procoagulant phosphatidylserine-positive platelet (Table) . The dependence of the unique subpopulation on integrin α IIb β 3 activation and its inhibition by eptifibatide 16 is consistent with a role for the activated integrin in the formation of these cytometric aggregates. Although the site of interaction between these 2 platelet types is not clearly demonstrated in this study, one can readily envision a mechanism in which activated integrin α IIb β 3 on the phosphatidylserine-negative platelet interacts with the fibrin(ogen) coat, or cap, 7, 33 on the phosphatidylserine-positive platelet generating the unique cytometric population. Multiple mechanisms may limit aggregate size in this in vitro setting, including the absence of stirring and the utilization of washed platelets, which limits extracellular fibrin(ogen) to that released by the activated platelet. In addition, the incorporation of the procoagulant platelet may function to limit aggregate propagation. 25, 26, 34 Notably, in cytometric assays, few if any aggregates were observed consisting of 2 phosphatidylserine-positive events, a finding consistent with the decreased aggregatory and adhesive ability of the procoagulant platelet.
The decreased adhesive qualities of the procoagulant platelet are well described. Procoagulant platelet formation is associated with a decrease in integrin α IIb β 3 function 26, 34 and decreased interaction of multiple platelet adhesive receptors with the platelet cytoskeleton. 25 On the contrary, retention of fibrin(ogen) is increased on the procoagulant platelet surface. 5 The association of procoagulant platelets with small aggregates of activated platelets demonstrated here suggests a model in which procoagulant platelets can participate in but not propagate aggregate formation. Procoagulant platelet participation in the aggregate can be mediated through the interaction of activated platelets with the fibrin(ogen) cap on the procoagulant platelet surface. However, the decreased integrin function of the procoagulant platelet would limit subsequent propagation of the aggregate. In vivo similar mechanisms could function within a forming hemostatic plug to mediate retention of a limited layer of procoagulant platelets observed here and in previous electron microscopy studies of the hemostatic plug. [35] [36] [37] Understanding of events occurring within individual platelets after agonist stimulation has been greatly enhanced by the use of cytometric techniques. By using flow cytometry, together with novel labeling and imaging techniques, IMM disruption is demonstrated to be a distinct mitochondrial event that is temporally associated with phosphatidylserine exposure in both agonist-stimulated (mPTP-mediated) and apoptotic (apoptosome/caspase-mediated) platelets. An interesting and outstanding question is whether a common mediator released from the mitochondrial matrix contributes to scramblase activation and phosphatidylserine externalization in the platelet. Continued delineation of the intracellular mechanisms regulating phosphatidylserine externalization is expected to provide novel insights allowing the therapeutic manipulation of procoagulant platelet formation in hemostatic and thrombotic conditions. 
Table. Properties of Cytometric Subpopulations
